Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Zimmerman

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|October 1, 1993
Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptorsD M Zimmerman, J D Leander, B E Cantrell, et al.
Journal of Neurochemistry|January 1, 1994
Molecular cloning, expression, and pharmacological characterization of humEAA1, a human kainate receptor subunitR K Kamboj, D D Schoepp, S Nutt, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
Structure-activity relationships of a series of benzothiophene-derived NPY Y1 antagonists: optimization of the C-2 side chainT C Britton, P G Spinazze, P A Hipskind, et al.
Journal of Medicinal Chemistry|July 21, 2001
[3H]N-2-(4-(N-benzamido)phenyl)propyl-2-propanesulfonamide: a novel AMPA receptor potentiator and radioligandH Zarrinmayeh, D Bleakman, M R Gates, et al.
Journal of Medicinal Chemistry|September 13, 1996
Synthesis of a series of aryl kainic acid analogs and evaluation in cells stably expressing the kainate receptor humGluR6B E Cantrell, D M Zimmerman, J A Monn, et al.
Journal of Medicinal Chemistry|September 18, 1992
6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonistsP L Ornstein, D D Schoepp, M B Arnold, et al.
Journal of Medicinal Chemistry|June 20, 1998
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonistsJ B Thomas, S W Mascarella, R B Rothman, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonistsH Zarrinmayeh, D M Zimmerman, B E Cantrell, et al.
Neuropharmacology|June 19, 2001
Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitroP Miu, K R Jarvie, V Radhakrishnan, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonistsJ B Thomas, S W Mascarella, J P Burgess, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|October 1, 1993
Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptorsD M Zimmerman, J D Leander, B E Cantrell, et al.
Journal of Neurochemistry|January 1, 1994
Molecular cloning, expression, and pharmacological characterization of humEAA1, a human kainate receptor subunitR K Kamboj, D D Schoepp, S Nutt, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
Structure-activity relationships of a series of benzothiophene-derived NPY Y1 antagonists: optimization of the C-2 side chainT C Britton, P G Spinazze, P A Hipskind, et al.
Journal of Medicinal Chemistry|July 21, 2001
[3H]N-2-(4-(N-benzamido)phenyl)propyl-2-propanesulfonamide: a novel AMPA receptor potentiator and radioligandH Zarrinmayeh, D Bleakman, M R Gates, et al.
Journal of Medicinal Chemistry|September 13, 1996
Synthesis of a series of aryl kainic acid analogs and evaluation in cells stably expressing the kainate receptor humGluR6B E Cantrell, D M Zimmerman, J A Monn, et al.
Journal of Medicinal Chemistry|September 18, 1992
6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonistsP L Ornstein, D D Schoepp, M B Arnold, et al.
Journal of Medicinal Chemistry|June 20, 1998
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonistsJ B Thomas, S W Mascarella, R B Rothman, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonistsH Zarrinmayeh, D M Zimmerman, B E Cantrell, et al.
Neuropharmacology|June 19, 2001
Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitroP Miu, K R Jarvie, V Radhakrishnan, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonistsJ B Thomas, S W Mascarella, J P Burgess, et al.
Pageof 5